CytoAgents

CytoAgents

A clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome.

Launch date
Employees
Market cap
-
Enterprise valuation
CAD38—57m (Dealroom.co estimates May 2023.)
Pittsburgh Pennsylvania (HQ)
Authorizing premium user...